UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39513 Outset Medical, Inc. (Exact name of Registrant as specified in its Charter) Delaware 20-0514392 (State or other jurisdiction of ...

Outset Medical, Inc. (NASDAQ:OM) Q4 2021 Earnings Conference Call February 16, 2022 5:00 PM ET Company Participants Jim Mazzola - VP, IR Leslie Trigg - CEO Nabeel Ahmed - CFO Conference Call Participants Amit Hazan - Goldman Sachs Josh Jennings - Cowen Suraj Kalia - Oppenheimer Rick Wise - Stifel Danielle Antalffy - SVB Leerink Drew Ranieri - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Outset Medical Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time ...

| --- | --- | |--------------------------------------|-------| | | | | | | | | | | | | | | | | Outset Medical Investor Presentation | | | November 2021 | | Forward-Looking Statements and Non-GAAP Information 2 This presentation and the accompanying oral statements contain forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are forward-looking statements. In some cases, you can identify forward-looking statements by terminology ...

Outset Medical, Inc. (NASDAQ:OM) Q3 2021 Earnings Conference Call November 3, 2021 5:00 PM ET Company Participants Brian Johnston - VP, IR, Gilmartin Group LLC Leslie Trigg - President and CEO Nabeel Ahmed - CFO Conference Call Participants Bob Hopkins - Bank of America Danielle Antalffy - SVB Leerink Josh Jennings - Cowen Drew Ranieri - Morgan Stanley Suraj Kalia - Oppenheimer Operator Ladies and gentlemen, thank you for standing by and welcome to the Outset Medical Third Quarter 2021 Earnings Conference C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdi ...

Outset Medical, Inc. (NASDAQ:OM) Q2 2021 Earnings Conference Call August 5, 2021 5:00 PM ET Company Participants Brian Johnston - Vice President, Investor Relations, Gilmartin Group LLC Leslie Trigg - President and Chief Executive Officer Nabeel Ahmed - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Drew Ranieri - Morgan Stanley Danielle Antalffy - SVB Leerink Shagun Singh - Wells Fargo Operator Good day and thank you for standing by. Welcome to the Outset Medical Q2 2021 Earnings C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdiction ...

Outset Medical, Inc. (NASDAQ:OM) Q1 2021 Earnings Conference Call May 5, 2021 5:00 PM ET Company Participants Lynn Lewis - IR Leslie Trigg - President and CEO Rebecca Chambers - CFO Conference Call Participants Jamie Perse - Goldman Sachs Drew Ranieri - Morgan Stanley Danielle Antalffy - SVB Leerink Rick Wise - Stifel Suraj Kalia - Oppenheimer & Company Shagun Singh - Wells Fargo Operator Ladies and gentlemen, thank you for standing by, and welcome to the Outset Medical First Quarter 2021 Earnings Conferenc ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdictio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐ NO ☒ For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39 ...